Relationships between Astrogliosis and ¹H MR Spectroscopic Measures of Brain Choline/Creatine and Myo-Inositol/Creatine in a Primate Model

References

1. ↵
   Greco JB, Westmoreland SV, Ratai EM, et al. In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med 2004;51:1108–1114

   CrossRefPubMed
2. ↵
   Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 1985;8:203–214

   CrossRefPubMedWeb of Science
3. ↵
   Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol 1994;4:229–237

   CrossRefPubMedWeb of Science
4. ↵
   Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem Res 2000;25:1439–1451

   CrossRefPubMedWeb of Science
5. ↵
   Kodama T, Mori K, Kawahara T, Ringler DJ, Desrosiers RC. Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J Virol 1993;67:6522–6534

   Abstract/FREE Full Text
6. ↵
   Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 1998;14:183–189

   CrossRefPubMedWeb of Science
7. ↵
   Desrosiers RC, Lifson JD, Gibbs JS, et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol 1998;72:1431–1437

   Abstract/FREE Full Text
8. ↵
   Tracey I, Lane J, Chang I, Navia B, Lackner A, Gonzalez RG. 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:21–27

   PubMed
9. ↵
   Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321–329

   CrossRefPubMedWeb of Science
10. ↵
    Fuller RA, Westmoreland SV, Ratai E, et al. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci 2004;5:10

    CrossRefPubMed
11. ↵
    Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365–373

    PubMedWeb of Science
12. ↵
    Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333–348

    CrossRefPubMedWeb of Science
13. ↵
    Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341–344

    CrossRefPubMedWeb of Science
14. ↵
    Mucke L, Oldstone MB, Morris JC, Nerenberg MI. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol 1991;3:465–474

    PubMedWeb of Science
15. ↵
    Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001;56:592–598

    Abstract/FREE Full Text
16. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry 1999;56:185–192

    CrossRefPubMedWeb of Science
17. Lazeyras F, Charles HC, Tupler LA, Erickson R, Boyko OB, Krishnan KR. Metabolic brain mapping in Alzheimer’s disease using proton magnetic resonance spectroscopy. Psychiatry Res 1998;82:95–106

    PubMedWeb of Science
18. Kantarci K, Jack CR Jr, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: a 1H MRS study. Neurology 2000;55:210–217

    Abstract/FREE Full Text
19. Huang W, Alexander GE, Chang L, et al. Brain metabolite concentration and dementia severity in Alzheimer’s disease: a (1)H MRS study. Neurology 2001;57:626–632

    Abstract/FREE Full Text
20. Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32:140–150

    CrossRefPubMedWeb of Science
21. Larsson HB, Christiansen P, Jensen M, et al. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 1991;22:23–31

    PubMedWeb of Science
22. Tourbah A, Stievenart JL, Gout O, et al. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis. Neurology 1999;53:1091–1097

    Abstract/FREE Full Text
23. Brooks WM, Friedman SD, Gasparovic C. Magnetic resonance spectroscopy in traumatic brain injury. J Head Trauma Rehabil 2001;16:149–164

    PubMedWeb of Science
24. ↵
    Garnett MR, Blamire AM, Corkill RG, Cadoux-Hudson TA, Rajagopalan B, Styles P. Early proton magnetic resonance spectroscopy in normal-appearing brain correlates with outcome in patients following traumatic brain injury. Brain 2000;123:2046–2054

    Abstract/FREE Full Text
25. ↵
    Delamillieure P, Constans JM, Fernandez J, et al. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr Bull 2002;28:329–339
26. Yamasue H, Fukui T, Fukuda R, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 2002;13:2133–2137

    CrossRefPubMedWeb of Science
27. ↵
    Fukuzako H, Kodama S, Fukuzako T, et al. Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy. Psychiatry Res 1999;92:45–56

    PubMed
28. ↵
    Falkai P, Honer WG, David S, Bogerts B, Majtenyi C, Bayer TA. No evidence for astrogliosis in brains of schizophrenic patients: a post-mortem study. Neuropathol Appl Neurobiol 1999;25:48–53

    PubMedWeb of Science
29. ↵
    Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995;195:58–64

    PubMedWeb of Science
30. ↵
    Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999;52:100–108

    Abstract/FREE Full Text
31. ↵
    Lopez-Villegas D, Lenkinski RE, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1997;94:9854–9859

    Abstract/FREE Full Text
32. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology 1996;46:783–788

    FREE Full Text
33. Laubenberger J, Haussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996;199:805–810

    PubMedWeb of Science
34. ↵
    Tarasow E, Wiercinska-Drapalo A, Kubas B, et al. Cerebral MR spectroscopy in neurologically asymptomatic HIV-infected patients. Acta Radiol 2003;44:206–212

    CrossRefPubMedWeb of Science
35. ↵
    Rausch DM. The SIV model of HIV-associated dementia. NeuroAIDS 1999;2
36. ↵
    Zink MC, Spelman JP, Robinson RB, Clements JE. SIV infection of macaques–modeling the progression to AIDS dementia. J Neurovirol 1998;4:249–259

    PubMedWeb of Science
37. ↵
    Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436–441

    CrossRefPubMedWeb of Science
38. ↵
    Desrosiers RC. The simian immunodeficiency viruses. Ann Rev Immunol 1990;8:557–578

    CrossRefPubMedWeb of Science
39. ↵
    Simon MA, Chalifoux LV, Ringler DJ. Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution. AIDS Res Hum Retroviruses 1992;8:327–337

    PubMedWeb of Science
40. ↵
    Gonzalez RG, Cheng LL, Westmoreland SV, et al. Early brain injury in the SIV-macaque model of AIDS. AIDS 2000;14:2841–2849

    CrossRefPubMed
41. ↵
    Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294–302

    CrossRefPubMedWeb of Science
42. Hwang JH, Graham GD, Behar KL, Alger JR, Prichard JW, Rothman DL. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 1996;35:633–639

    PubMedWeb of Science
43. Mader I, Seeger U, Weissert R, et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. Brain 2001;124:953–961

    Abstract/FREE Full Text
44. ↵
    Seeger U, Klose U, Mader I, Grodd W, Nagele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19–28

    CrossRefPubMedWeb of Science